HomeProfessionals MSc, MD, Doctor Nong Ngoc Son
MSc, MD, Doctor
Nong Ngoc Son
Booking
Overview

MD. Nong Ngoc Son has many years’ experience in treatment for patients with cancer, especially in chemotherapy, metastasized late stage and end-stage cancer. He was trained domestically and internationally such as Harvard University of Medicine, Japan Institute of Biotherapy before being Chemotherapist and Palliative Doctor at Vinmec Central Park International Hospital as present.

Specialties
Chemotherapist and Palliative Doctor
Services
  • Diagnosis and treatment plan for lung, breast, colon, duodenal and gastric cancer
  • Chemotherapy and palliative care for its side effect
  • Palliative care for patient at late stage and end stage
  • Immunotherapy and biotherapy.

General Practitioner at Ho Chi Minh City University of Medicine and Pharmacy


Resident Physician in Oncology at Ho Chi Minh City University of Medicine and Pharmacy


Master Degree in Oncology at Ho Chi Minh City University of Medicine and Pharmacy


First Degree Specialist in Oncology at Ho Chi Minh City University of Medicine and Pharmacy


2013: Basic training in palliative care by Harvard University for Oncologist in Ho Chi Minh City


2014: Certificate of early screening and detection of cancer at Ho Chi Minh City University of Medicine and Pharmacy


2015: Training program for lecturer in Palliative Care which is cooperated with Harvard University of Medicine and Ho Chi Minh City Hospital of Oncology


2018: Trained in autologous immune enhancement therapy at Tokyo Clinic, Japan Institute of Biotherapy


2018: Trained in coordinated multimodal therapy for cancer at Sun Yat Set Koo Foundation Cancer Center, Taiwan


Internist at District 2 Hospital, Ho Chi Minh City


Residency Doctor in Oncology at Ho Chi Minh City Hospital of Oncology


Oncology Department - Vinmec Central Park International Hospital


  • ‘TSH and papillary thyroid cancer’ – the 10th International Conference of Cancer, Seoul, Korea, 2012
  • ‘Prognosis of life time for patients with terminal cancer HCMC Conference of Cancer Prevention, 2015.